Search

Bevacizumab Adds Little to Adjuvant Chemo for Colon Cancer

Bevacizumab Adds Little to Adjuvant Chemo for Colon Cancer

Adding the anti-VEGF monoclonal antibody bevacizumab to state-of-the-art adjuvant chemotherapy for stage II or III colon cancer does not improve disease-free survival, according to a report in the Journal of Clinical Oncology online October 1.